Weiyi Xu

1.0k total citations
30 papers, 723 citations indexed

About

Weiyi Xu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Weiyi Xu has authored 30 papers receiving a total of 723 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Weiyi Xu's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (3 papers). Weiyi Xu is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (3 papers). Weiyi Xu collaborates with scholars based in China, United States and Hong Kong. Weiyi Xu's co-authors include Songshan Jiang, Jianwen Zhou, Peng Zhou, Haixiong Xu, Lilei Zhang, Ping Gao, Tao Zhu, Xiaoni Li, Xin Liu and Peter E. Lobie and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Development.

In The Last Decade

Weiyi Xu

29 papers receiving 717 citations

Peers

Weiyi Xu

IMMUN

PHYSI

ONCOL

Gang Wei China

Monika Deshpande United States

Liudi Yuan China

Allison B. Herman United States

Je Yeong Ko South Korea

Vivian Utti United States

Zachary Spicer United States

Gregory S. McElroy United States

Susann Schindler Germany

Jimena Druker Argentina

Gang Wei China

Weiyi Xu

808 ×1.7

282 ×0.8

73 ×0.8

IMMUN

97 ×1.6

PHYSI

58 ×1.1

ONCOL

Citations per year, relative to Weiyi Xu Weiyi Xu (= 1×) peers Gang Wei

Countries citing papers authored by Weiyi Xu

Since Specialization

Citations

This map shows the geographic impact of Weiyi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyi Xu more than expected).

Fields of papers citing papers by Weiyi Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyi Xu. The network helps show where Weiyi Xu may publish in the future.

Co-authorship network of co-authors of Weiyi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyi Xu. A scholar is included among the top collaborators of Weiyi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyi Xu. Weiyi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Weiyi, et al.. (2025). AI-assisted Automatic Jump Detection and Height Estimation in Volleyball Using a Waist-worn IMU. PubMed. 2025. 1–7.

Kong, Yun Cheung, et al.. (2024). Efficacy and action mechanisms of compound Shen Chan decoction on experimental models of atopic dermatitis. International Immunopharmacology. 137. 112479–112479. 3 indexed citations

Xu, Weiyi, et al.. (2024). Unraveling MLL1-fusion leukemia: Epigenetic revelations from an iPS cell point mutation. Journal of Biological Chemistry. 300(11). 107825–107825. 1 indexed citations

Zuo, Tiantian, Jing Liu, Ke Zan, et al.. (2024). Bioaccessibility and bioavailability of exogenous and endogenous toxic substances in traditional Chinese medicine and their significance in risk assessment. Pharmacological Research. 208. 107388–107388. 3 indexed citations

Xu, Weiyi, et al.. (2024). Hic-5 regulates extracellular matrix-associated gene expression and cytokine secretion in cancer associated fibroblasts. Experimental Cell Research. 435(2). 113930–113930. 2 indexed citations

Xu, Weiyi, Liang Sun, Ji‐Eun Kim, et al.. (2024). Folate as a potential treatment for lethal ventricular arrhythmias in TANGO2-deficiency disorder. JCI Insight. 9(11). 3 indexed citations

Hayes, Matthew, Danesh H. Sopariwala, Ryan L. Sanders, et al.. (2024). The Estrogen Receptor-Related Orphan Receptors Regulate Autophagy through TFEB. Molecular Pharmacology. 106(4). 164–172. 2 indexed citations

Song, Shiyang, Lei Qi, Hui Li, et al.. (2022). REV-ERB is essential in cardiac fibroblasts homeostasis. Frontiers in Pharmacology. 13. 899628–899628. 8 indexed citations

Li, Hongli, Qianyu Li, Weiyi Xu, et al.. (2021). A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression. Journal of Cancer Research and Clinical Oncology. 147(6). 1569–1585. 37 indexed citations

10.

Zhang, Zhao, Bin Yan, Fei Gao, et al.. (2020). PSCs Reveal PUFA-Provoked Mitochondrial Stress as a Central Node Potentiating RPE Degeneration in Bietti’s Crystalline Dystrophy. Molecular Therapy. 28(12). 2642–2661. 31 indexed citations

11.

Yu, Fei, et al.. (2020). Downregulation of miRNA‑663b protects against hypoxia‑induced injury in cardiomyocytes by targeting BCL2L1. Experimental and Therapeutic Medicine. 19(6). 3581–3588. 5 indexed citations

12.

Xu, Weiyi, et al.. (2020). Paxillin family of focal adhesion adaptor proteins and regulation of cancer cell invasion. International review of cell and molecular biology. 355. 1–52. 31 indexed citations

13.

Xu, Weiyi, Le Li, & Lilei Zhang. (2020). NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death. Frontiers in Physiology. 11. 901–901. 21 indexed citations

14.

Xu, Weiyi, et al.. (2019). Paxillin-dependent regulation of apical-basal polarity in mammary gland morphogenesis. Development. 146(9). 14 indexed citations

15.

Xie, Chen, Wei Chen, Mengdie Zhang, et al.. (2015). MDM4 regulation by the let‐7 miRNA family in the DNA damage response of glioma cells. FEBS Letters. 589(15). 1958–1965. 18 indexed citations

16.

Zhou, Jianwen, Wei Wang, Zhenhua Gao, et al.. (2013). MicroRNA-155 Promotes Glioma Cell Proliferation via the Regulation of MXI1. PLoS ONE. 8(12). e83055–e83055. 53 indexed citations

17.

Zhou, Peng, Weiyi Xu, Zhenhua Luo, et al.. (2013). Large-Scale Screens of miRNA-mRNA Interactions Unveiled That the 3′UTR of a Gene Is Targeted by Multiple miRNAs. PLoS ONE. 8(7). e68204–e68204. 58 indexed citations

18.

Li, Xiaoni, Xin Liu, Weiyi Xu, et al.. (2013). c-MYC-regulated miR-23a/24-2/27a Cluster Promotes Mammary Carcinoma Cell Invasion and Hepatic Metastasis by Targeting Sprouty2. Journal of Biological Chemistry. 288(25). 18121–18133. 123 indexed citations

19.

Yang, Yan, Huachun Cui, Songshan Jiang, et al.. (2011). Identification of a Novel Marine Fish Virus, Singapore Grouper Iridovirus-Encoded MicroRNAs Expressed in Grouper Cells by Solexa Sequencing. PLoS ONE. 6(4). e19148–e19148. 42 indexed citations

20.

Nishimura, Michiko, et al.. (1996). The bacteriological study of the Cariostat test : Part 1 The determination of the incubation time of the Cariostat agar based from the visible and countable colony-formation on the agar. 6(1). 57–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact